Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson's Disease

This open-label study aimed to compare once-daily and twice-daily pramipexole extended release (PER) treatment in Parkinson's disease (PD). PD patients on dopamine agonist therapy, but with unsatisfactory control, were enrolled. Existing agonist doses were switched into equivalent PER doses. Su...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Parkinsons Dis
Autors principals: Yun, Ji Young, Kim, Young Eun, Yang, Hui-Jun, Kim, Han-Joon, Jeon, Beomseok
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2017
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318624/
https://ncbi.nlm.nih.gov/pubmed/28265478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8518929
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars